Bio-Works Technologies AB (BIOWKS)
Market Closed
10 Aug, 15:25
XSTO XSTO Primary kr
3. 20
-0.06
-1.8405%
kr
322.33M Market Cap
- P/E Ratio
- Div Yield
43,413 Volume
-1.39 Eps
kr 3.26
Previous Close Want to track BIOWKS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
BIOWKS closed today lower at kr3.2, a decrease of -1.8405% from yesterday's close, completing a monthly increase of 1.9108% or kr0.06. Over the past 12 months, BIOWKS stock gained 16.3636%.
BIOWKS is not paying dividends to its shareholders.
The last earnings report, released on May 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Bio-Works Technologies AB (BIOWKS) FAQ
What is the stock price today?
The current price is kr3.20.
On which exchange is it traded?
Bio-Works Technologies AB is listed on XSTO.
What is its stock symbol?
The ticker symbol is BIOWKS.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 322.33M.
Has Bio-Works Technologies AB ever had a stock split?
No, there has never been a stock split.
Bio-Works Technologies AB Profile
| Biotechnology Industry | Healthcare Sector | Ms. Lone Carlbom CEO | XSTO Exchange | SE0007387089 ISIN |
| SE Country | 33 Employees | - Last Dividend | 3 Jun 2019 Last Split | - IPO Date |
Overview
Bio-Works Technologies AB (publ) is a prominent biotechnology firm based in Uppsala, Sweden, focused on the research, development, manufacture, and distribution of innovative agarose-based separation products for the biopharmaceutical industry. Since its establishment in 2006, the company has dedicated itself to providing high-quality solutions designed to purify proteins, peptides, and other biomolecules. With a strong emphasis on Sweden, Bio-Works Technologies serves a global market, catering to the rigorous purification needs of research, diagnostics, and therapeutic applications. Its commitment to excellence and innovation has positioned Bio-Works Technologies as a trusted partner in biomanufacturing and research.
Products and Services
- Activated and Affinity Resins - These resins are designed for the purification of antibodies, proteins, and other biomolecules through selective binding. They are critical for applications requiring high purity levels, such as pharmaceutical manufacturing and research.
- GoBio Mini columns - Compact columns prepacked with high-performance resins suitable for small-scale purification and sample preparation. These mini-columns are ideal for quick screenings and process optimization.
- Immobilized Metal-ion Affinity Chromatography (IMAC) Resins - Specialized resins used for the purification of his-tagged proteins by exploiting the affinity of histidine residues for metal ions. This technology is essential for the isolation of recombinant proteins.
- Ion Exchange Resins - These resins separate biomolecules based on their charge differences, a fundamental technique for purifying a wide range of biomolecules, including proteins and peptides.
- RoboColumns and Optimo PRO 96 Well Screens - These products offer automated and high-throughput solutions for resin screening, process development, and optimization, addressing the needs of fast-paced research and production settings.
- Screening Kits - Comprehensive kits designed to aid in the selection of the most suitable resins and purification strategies for specific biomolecules, thereby streamlining the purification process.
- Size Exclusion Chromatography Resins - Utilized for purifying proteins, peptides, oligonucleotides, viruses, and vaccines based on size differences. These resins are indispensable for applications requiring high-resolution separations.
Contact Information
Address: Virdings allé 18, Uppsala, Sweden, 754 50
Phone: 46 8 56 26 74 30
Website: https://www.bio-works.com
